The oxidation of dopamine and epinine by the two forms of monoamine oxidase from rat liver
Information on the “in vitro” oxidation of epinine by monoamine oxidase (MAO) compared to dopamine is very poor. The aim of this work was to study the oxidative deamination of epinine and dopamine by rat liver MAO-A and MAO-B.
The contributions of MAO-A and B to the metabolism of dopamine (55% and 45%, respectively) and epinine (70% and 30%, respectively) were similar. The results of this study show that epinine is a substrate for both forms of MAO in rat liver, although the contribution of MAO A to the deamination of this secondary amine appears to be slightly more important than that of MAO B.
KeywordsMonoamine Oxidase Secondary Amine Liver Homogenate Oxidative Deamination Dihydroxyphenylacetic Acid
Unable to display preview. Download preview PDF.
- Lodola E, Borgia M, Longo A, Pocchiari F, Pataccini R, Sher D (1986) Ibopamine kinetics after a single oral dose in healthy volunteers. Arzneimittelforschung/Drug Res 36: 345–348Google Scholar
- Pocchiari F, Pataccini R, Castelnovo P, Longo A, Casagrande C (1986a) Ibopamine, an orally active dopamine-like drug: metabolism and pharmacokinetics in rats. Arzneimittelforschung/Drug Res 36: 334–340Google Scholar
- Pocchiari F, Pataccini R, Castelnovo P, Longo A, Paro M, Casagrande C (1986b) Ibopamine, an orally active dopamine-like drug: metabolism and pharmacokinetics in dogs. Arzneimittelforschung/Drug Res 36: 341–344Google Scholar
- Strolin Benedetti M, Dostert P, Guffroy C, Tipton KF (1983) Partial or total protection from long-acting monoamine oxidase inhibitors (MAOIs) by new short-acting MAOIs of type A MD780515 and type B MD780236. Mod Probl Pharmacopsychiat 19: 82–104Google Scholar